ROLE OF CD44 AND CD7 MOLECULES IN MEDIATION OF INFLAMMATORY SYNOVITIS
CD44 和 CD7 分子在调节炎性滑膜炎中的作用
基本信息
- 批准号:6348929
- 负责人:
- 金额:$ 21.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2001-08-31
- 项目状态:已结题
- 来源:
- 关键词:CD antigens CD44 molecule T cell receptor T lymphocyte cell cell interaction cytokine genetically modified animals human T cell lymphotropic virus type 1 human tissue hyaluronate hypertrophic osteoarthropathy immunopathology interferon gamma laboratory mouse monocyte protein isoforms rheumatoid arthritis synovitis tissue /cell culture
项目摘要
Monocyte-T cell interactions are key events in mediation of pathologic
immune responses. The broad objectives of this project are to study
roles that T cells and monocytes play in rheumatoid arthritis (RA), by
focusing on the roles that CD44 isoforms and CD7 deficient T cells play
in the pathogenesis of RA and in animal models of inflammatory
synovitis. These objectives will be accomplished by the use of
peripheral blood (PB), synovial fluid (SF) and synovial tissue from
patients with RA, as well as evaluation of a series of novel CD44 and
CD7 deficient mouse strains for their ability to develop synovitis when
injected with challenge antigens or when bred to mice susceptible to
HTLV-l tax transgenic mouse arthritis. Specific aims for Project l are
as follows: l) We will study the roles of cytokines in vivo and in vitro
in regulation of hyaluronan (HA) binding to CD44 isoforms on monocytes
and other synovial cell types in RA, and in tax transgenic mice and mice
with collagen-induced arthritis. Study of the cytokines that regulate HA
binding (and therefore HA-induced proinflammatory events) in RA and in
animal models of RA-like synovitis are critical to development of novel
interventional strategies for treatment of RA. 2) We will define the
roles of CD44 isoforms in inflammatory synovitis using: a) total CD44
deficient mice. b) mice selectively deficient only in variant CDT forms
(but expressing the standard CD44 form. CD44S), and c) mice only
expressing select variant CD44 isoforms. CD44 deficient mice will be
studied for their response to antigen-induced arthritis (AIA). and bred
on a HTLV-l tax transgenic background to determine the effect of CD44
selective and total deficiencies on arthritis in HTLV- l tax transgenic
mice. 3) We will study the roles of CD7 deficient T cells and an altered
TCR repertoire in mediation of inflammatory synovitis by isolating CD4+,
CD7-, CD28- T cells from RA and OA PBMC. SF and synovial tissue and
determining the ability of these T cells to produce IFN-gamma and other
cytokines/chemokines in response to T cell activation signals, and by
studying CD7 deficient mice, in the presence and absence of abnormal T
cell receptor (TCR) repertoires in TCR transgenic mice, for their
ability to develop arthritis. Taken together these studies will provide
insight into the roles that T cells and monocytes play in inflammatory
synovitis. and provide new targets for novel therapeutic interventions
in RA.
单核细胞-T细胞相互作用是介导病理性免疫缺陷的关键事件。
免疫反应。该项目的主要目标是研究
T细胞和单核细胞在类风湿性关节炎(RA)中的作用,
关注CD44亚型和CD7缺陷型T细胞的作用
在RA的发病机制和炎症的动物模型中,
滑膜炎这些目标将通过使用
外周血(PB)、滑液(SF)和滑膜组织
RA患者,以及一系列新的CD44和
CD7缺陷型小鼠品系在以下情况下发生滑膜炎的能力:
注射攻击抗原或当与易感
HTLV-ltax转基因小鼠关节炎。项目1的具体目标是
主要内容如下:1)研究细胞因子在体内外的作用
调节透明质酸(HA)与单核细胞上CD44亚型的结合
和其他滑膜细胞类型,以及tax转基因小鼠和
患有胶原性关节炎调节HA的细胞因子的研究
结合(因此HA诱导的促炎事件)在RA和
RA样滑膜炎的动物模型对于开发新的
RA的介入治疗策略。2)我们将定义
CD44亚型在炎性滑膜炎中的作用:a)总CD44
缺陷小鼠B)仅在变体CDT形式中选择性缺陷的小鼠
(but表达标准的CD44形式。CD44S),和c)仅小鼠
表达选择的变体CD44同种型。CD44缺陷型小鼠将
研究它们对抗原诱导的关节炎(AIA)的反应。和长大
在HTLV-1 tax转基因背景下,以确定CD44
HTLV-1 Tax转基因动物关节炎的选择性和总体缺陷
小鼠3)我们将研究CD7缺陷型T细胞的作用,
通过分离CD4+介导炎性滑膜炎的TCR库,
来自RA和OA PBMC的CD7-、CD28-T细胞。SF和滑膜组织,以及
确定这些T细胞产生IFN-γ和其他干扰素的能力,
细胞因子/趋化因子,并通过
研究CD7缺陷小鼠,在存在和不存在异常T细胞的情况下,
细胞受体(TCR)库在TCR转基因小鼠,为他们的
发展关节炎的能力。这些研究将提供
深入了解T细胞和单核细胞在炎症反应中的作用
滑膜炎并为新的治疗干预提供新的靶点
在RA中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barton F. Haynes其他文献
Human thymic epithelium and T cell development: current issues and future directions.
人类胸腺上皮和 T 细胞发育:当前问题和未来方向。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Barton F. Haynes - 通讯作者:
Barton F. Haynes
Mechanisms of corticosteroid action on lymphocyte subpopulations. IV. Effects of in vitro hydrocortisone on naturally occuring and mitogen-induced suppressor cells in man.
皮质类固醇对淋巴细胞亚群的作用机制。
- DOI:
- 发表时间:
1979 - 期刊:
- 影响因子:4.3
- 作者:
Barton F. Haynes;A. Fauci - 通讯作者:
A. Fauci
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture
混合淋巴细胞培养物中人溶细胞性 T 淋巴细胞的表型特征
- DOI:
- 发表时间:
1981 - 期刊:
- 影响因子:15.3
- 作者:
A. Moretta;M. Mingari;Barton F. Haynes;R. Sékaly;L. Moretta;A. Fauci - 通讯作者:
A. Fauci
Early corneal findings in Cogan's syndrome.
科根综合征的早期角膜发现。
- DOI:
10.1016/s0161-6420(84)34215-4 - 发表时间:
1984 - 期刊:
- 影响因子:13.7
- 作者:
L. Michael Cobo;Barton F. Haynes - 通讯作者:
Barton F. Haynes
Human Erythrocyte Antigens: II. The <em>In(Lu)</em> Gene Regulates Expression of an Antigen on an 80-Kilodalton Protein of Human Erythrocytes
- DOI:
10.1182/blood.v64.3.599.599 - 发表时间:
1984-09-01 - 期刊:
- 影响因子:
- 作者:
Marilyn J. Telen;Thomas J. Palker;Barton F. Haynes - 通讯作者:
Barton F. Haynes
Barton F. Haynes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barton F. Haynes', 18)}}的其他基金
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
项目3:核苷修饰mRNA-LNP疫苗平台
- 批准号:
10842504 - 财政年份:2021
- 资助金额:
$ 21.36万 - 项目类别:
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
项目3:核苷修饰mRNA-LNP疫苗平台
- 批准号:
10327525 - 财政年份:2021
- 资助金额:
$ 21.36万 - 项目类别:
Design and Development of a Pan-betacoronavirus Vaccine
泛β冠状病毒疫苗的设计与开发
- 批准号:
10842498 - 财政年份:2021
- 资助金额:
$ 21.36万 - 项目类别:
Design and Development of a Pan-betacoronavirus Vaccine
泛β冠状病毒疫苗的设计与开发
- 批准号:
10327519 - 财政年份:2021
- 资助金额:
$ 21.36万 - 项目类别:
相似海外基金
Inhibition of tumor growth, invasion, and metastasis by targeting CD44 molecule
靶向CD44分子抑制肿瘤生长、侵袭和转移
- 批准号:
13557094 - 财政年份:2001
- 资助金额:
$ 21.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
- 批准号:
2770673 - 财政年份:1997
- 资助金额:
$ 21.36万 - 项目类别:
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
- 批准号:
2471152 - 财政年份:1997
- 资助金额:
$ 21.36万 - 项目类别:
Study on CD44 molecule in follicular lymphoma
滤泡性淋巴瘤中CD44分子的研究
- 批准号:
07670232 - 财政年份:1995
- 资助金额:
$ 21.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




